Literature DB >> 2049225

Frequent loss of a p53 allele in carcinomas and their precursors in ulcerative colitis.

G C Burmer1, D A Crispin, V R Kolli, R C Haggitt, B G Kulander, C E Rubin, P S Rabinovitch.   

Abstract

Allelic deletions of the p53 gene previously were demonstrated by Southern hybridization to occur in high frequency in sporadic colon carcinomas and in a variety of other human tumors. We have examined the frequency of allelic loss of the p53 gene in carcinoma and dysplasia arising in patients with chronic ulcerative colitis who are heterozygous for the codon 72 polymorphism in exon 4 of the p53 gene. Cells derived from carcinoma and dysplasia specimens from 10 patients who were heterozygous at this locus were sorted by flow cytometry on the basis of DNA content. The p53 exon 4 region was amplified from diploid and aneuploid populations, via a polymerase chain reaction (PCR), and digested with BstUI. Three of three carcinomas, four of six dysplasias, and one patient who was indefinite for dysplasia demonstrated evidence of allelic loss of the p53 gene. Seven of ten cases of sporadic colon carcinoma, analyzed for comparative purposes, exhibited loss of a p53 allele. These results demonstrate that PCR analysis, followed by restriction endonuclease digestion of a polymorphic locus, can provide a rapid, definitive method for analyzing loss of heterozygosity in small numbers of cells from colonic mucosa. Such loss precedes cancer in ulcerative colitis and can be present in its earliest histologically identifiable precursor.

Entities:  

Mesh:

Year:  1991        PMID: 2049225     DOI: 10.3727/095535491820873254

Source DB:  PubMed          Journal:  Cancer Commun        ISSN: 0955-3541


  13 in total

1.  p53 mutations are associated with dysplasia and progression of dysplasia in patients with Crohn's disease.

Authors:  Jeffrey W Nathanson; Nicole E Yadron; Jeanne Farnan; Sydney Kinnear; John Hart; David T Rubin
Journal:  Dig Dis Sci       Date:  2007-08-04       Impact factor: 3.199

Review 2.  Biology of colorectal cancer in ulcerative colitis.

Authors:  B A Lashner; B D Shapiro
Journal:  J Gastrointest Surg       Date:  1998 Jul-Aug       Impact factor: 3.452

Review 3.  Molecular Alterations of Colorectal Cancer with Inflammatory Bowel Disease.

Authors:  Masakazu Yashiro
Journal:  Dig Dis Sci       Date:  2015-04-04       Impact factor: 3.199

4.  Genomic instability is an early event during the progression pathway of ulcerative-colitis-related neoplasia.

Authors:  R F Willenbucher; D E Aust; C G Chang; S J Zelman; L D Ferrell; D H Moore; F M Waldman
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

5.  Microsatellite instability is absent in liver and biliary mucosa of patients with primary sclerosing cholangitis.

Authors:  S Y Jin; A E Noffsinger; P Bejarano; F L Weber; D W Hanto; J M Belli; C M Fenoglio-Preiser
Journal:  Dig Dis Sci       Date:  1999-03       Impact factor: 3.199

6.  Microsatellite instability is uncommon in intestinal mucosa of patients with Crohn's disease.

Authors:  A Noffsinger; S Kretschmer; J Belli; F Fogt; C Fenoglio-Preiser
Journal:  Dig Dis Sci       Date:  2000-02       Impact factor: 3.199

7.  K-ras mutations and p53 alterations in neoplastic and nonneoplastic lesions associated with longstanding ulcerative colitis.

Authors:  P Chaubert; J Benhattar; E Saraga; J Costa
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

8.  Markers for dysplasia of the upper aerodigestive tract. Suprabasal expression of PCNA, p53, and CK19 in alcohol-fixed, embedded tissue.

Authors:  M D Coltrera; R J Zarbo; W A Sakr; A M Gown
Journal:  Am J Pathol       Date:  1992-10       Impact factor: 4.307

9.  Expression of growth factor receptor-encoded mRNA by colonic epithelial cells is altered in inflammatory bowel disease.

Authors:  R J Alexander; A Panja; E Kaplan-Liss; L Mayer; R F Raicht
Journal:  Dig Dis Sci       Date:  1995-03       Impact factor: 3.199

Review 10.  Animal models of gastrointestinal and liver diseases. New mouse models for studying dietary prevention of colorectal cancer.

Authors:  James C Fleet
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-05-29       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.